CellLife+ is a trusted leader in non-cultured mesenchymal stem cells (MSCs), developed from pioneering research conducted in a top-tier Australian laboratory. Since 2018, we have been delivering high-quality MSC solutions to the Malaysian market, setting new standards in safety, efficacy, and innovation.

Rigorous Donor Pre-Screening

To ensure the integrity of our MSC source, all donor parents undergo comprehensive pre-screening. Donors with any history of chronic illness are excluded from the program, guaranteeing only the highest-quality umbilical cord tissue is used.

Controlled Manufacturing Environment

Our MSCs are produced in a strictly controlled, closed manufacturing system that prevents exposure to open environments, significantly minimizing contamination risks. We use the industry-standard 7-AAD viability assay along with flow cytometry to ensure precise and reliable quality control.

Every customer who undergoes stem cell therapy with us receives a detailed flow cytometry report and non-contamination lab test report (independent TGA registered lab) for full transparency and peace of mind.

Commitment to Safety and Quality Assurance

CellLife+ products are protected by a Product Liability Insurance policy of AUD 20 million, underwritten by Lloyd’s of London—the world’s largest life science underwriter. This robust insurance coverage reflects our unwavering commitment to product safety and the confidence given to our customers.